Señales en vivo de CLN.WA | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 may 2024 @ 11:00):

Stats
Volumen de hoy	49 759.00
Volumen promedio	19 089.00
Capitalización de mercado	792.40M
EPS	PLN-0.130 ( 2023-11-22 )
Próxima fecha de ganancias	( PLN0 ) 2024-05-22
Last Dividend	PLN0.0900 ( 2023-06-29 )
Next Dividend	PLN0 ( N/A )
P/E	-28.22
ATR14	PLN0.0350 (0.23%)

Volumen Correlación

Largo: 0.07 (neutral)

Corto: -0.65 (moderate negative)

Signal:(45.475) Neutral

Celon Pharma S.A. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Celon Pharma S.A. Correlación - Moneda/Commodity

-0.61
( weak negative )

-0.78
( moderate negative )

0.00
( neutral )

-0.58
( weak negative )

0.47
( neutral )

0.71
( moderate )

Celon Pharma S.A. Finanzas

Annual	2023
Ingresos:	PLN164.39M
Beneficio Bruto:	PLN97.58M (59.35 %)
EPS:	PLN-0.550

FY	2023
Ingresos:	PLN164.39M
Beneficio Bruto:	PLN97.58M (59.35 %)
EPS:	PLN-0.550

FY	2022
Ingresos:	PLN161.92M
Beneficio Bruto:	PLN95.45M (58.95 %)
EPS:	PLN-0.770

FY	2021
Ingresos:	PLN169.56M
Beneficio Bruto:	PLN107.84M (63.60 %)
EPS:	PLN-0.111

Financial Reports:

No articles found.

Celon Pharma S.A. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0.0900 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)	PLN0 (N/A)

Celon Pharma S.A. Dividend Information - No Dividend Player

Dividend Sustainability Score: 1.652 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	PLN0.170	2017-05-31
Last Dividend	PLN0.0900	2023-06-29
Next Dividend	PLN0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	7	--
Total Paid Out	PLN1.110	--
Avg. Dividend % Per Year	0.00%	--
Score	0.73	--
Div. Sustainability Score	1.652
Div.Growth Potential Score	0
Div. Directional Score	0.537	--

Next Divdend (Est)
(2025-04-08)

PLN0.0386 Estimate 3.10 %

Dividend Stability

0.25 Very Poor

Dividend Score

0.73

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for WSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
R22.WA	Ex Dividend Junior	2023-08-29	Annually	0.00%
CLN.WA	No Dividend Player	2023-06-29	Annually	0.00%
OEX.WA	Ex Dividend Junior	2023-07-06	Sporadic	0.00%
BDX.WA	Ex Dividend Knight	2023-05-24	Annually	0.00%
LSI.WA	Ex Dividend Junior	2023-08-16	Sporadic	0.00%
APR.WA	Ex Dividend Junior	2023-05-31	Sporadic	0.00%
WWL.WA	Ex Dividend Knight	2023-07-13	Annually	0.00%
IFI.WA	Ex Dividend Knight	2023-09-06	Quarterly	0.00%
SNK.WA	Ex Dividend Knight	2023-07-05	Annually	0.00%
DOM.WA	Ex Dividend Knight	2023-06-23	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.135	1.500	-2.69	-4.04	[0 - 0.5]
returnOnAssetsTTM	-0.0388	1.200	-1.295	-1.554	[0 - 0.3]
returnOnEquityTTM	-0.0481	1.500	-1.645	-2.47	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.20	0.800	4.01	3.21	[1 - 3]
quickRatioTTM	1.893	0.800	3.57	2.86	[0.8 - 2.5]
cashRatioTTM	0.375	1.500	9.03	10.00	[0.2 - 2]
debtRatioTTM	0.0449	-1.500	9.25	-10.00	[0 - 0.6]
interestCoverageTTM	-8.21	1.000	-4.15	-4.15	[3 - 30]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0539	-0.108	[0 - 30]
freeCashFlowPerShareTTM	-0.801	2.00	-0.400	-0.801	[0 - 20]
debtEquityRatioTTM	0.0574	-1.500	9.77	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.606	1.000	3.24	3.24	[0.2 - 0.8]
operatingProfitMarginTTM	-0.131	1.000	-4.62	-4.62	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.325	1.000	-2.92	-2.92	[0.2 - 2]
assetTurnoverTTM	0.289	0.800	-1.408	-1.127	[0.5 - 2]
Total Score				1.652

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-36.05	1.000	-3.74	0	[1 - 100]
returnOnEquityTTM	-0.0481	2.50	-1.058	-2.47	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.801	2.00	-0.267	-0.801	[0 - 30]
dividendYielPercentageTTM	0.580	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0539	-0.108	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0506	1.000	-3.76	0	[0.1 - 0.5]
Total Score				-0.579

Celon Pharma S.A.

Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.